glipizide has been researched along with tolbutamide in 69 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 28 (40.58) | 18.7374 |
1990's | 16 (23.19) | 18.2507 |
2000's | 11 (15.94) | 29.6817 |
2010's | 13 (18.84) | 24.3611 |
2020's | 1 (1.45) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Gozalbes, R; Pineda-Lucena, A | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Melander, A; Wåhlin-Boll, E | 2 |
Balant, L | 1 |
Gotfredsen, CF | 1 |
Garcia, SD; Jarrousse, C; Rosselin, G | 1 |
Hed, R; Nygren, A; Röjdmark, R; Sundblad, L; Wiechel, KL | 1 |
Bandisode, MS; Boshell, BR | 1 |
Müller, WE; Wollert, U | 1 |
Alric, R; Loubatières, AL; Loubatieres-Mariani, MM; Ribes, G; Sorial, G; Tarasco, A | 1 |
Alric, R; Lignon, F; Loubatières, A; Manteghetti, M; Puech, R | 1 |
Aguilar-Bryan, L; Bryan, J; Nelson, DA | 1 |
Harrower, AD | 1 |
Aranyi, Z; Ballagi-Pordány, G; Koltai, MZ; Köszeghy, A; Pogátsa, G | 1 |
Boutagy, JS; Shenfield, GM; Webb, C | 1 |
Dash, RJ; Khandekar, S; Sethi, BK | 1 |
Berbil-Bautista, PR; Felíu, JE; Guijarro, C; López-Alarcón, L; Melián, E | 1 |
Lenzen, S; Männer, K; Panten, U; Trube, G; Zünkler, BJ | 1 |
Wilson, C | 1 |
Felíu, JE; Marcos, ML; Mojena, M; Monge, L | 1 |
Cabello, MA; Felíu, JE; Monge, L; Ortega, JL; Samper, B | 1 |
Ali, L; Hellman, B; Wesslén, N | 1 |
Pollet, RJ; Rogers, BJ; Standaert, ML | 1 |
Boyd, AE; Gaines, KL; Hamilton, S | 1 |
Hellman, B; Sehlin, J; Täljedal, IB | 1 |
Alberetto, M; Baio, G; Bertoletti, A; Pontiroli, AE; Pozza, G | 1 |
Loubatieres-Mariani, MM | 1 |
Melander, A; Sartor, G; Scherstén, B; Wåhlin-Boll, E | 2 |
Brasseur, R; Deleers, M; Gelbcke, M; Malaisse, WJ | 1 |
Fineberg, SE; Schneider, SH | 1 |
Bommartini, F; Emanueli, A; Freddo, J; Pedrazzi, F | 1 |
Groop, L; Tötterman, KJ | 1 |
Fagerlund, C; Gyllenhaal, O; Hartvig, P | 1 |
Arfors, KE; Bergqvist, D; Tangen, O | 1 |
Bachmann, C; Chudziak, F; Löser, S; Panten, U; Schwanstecher, M | 1 |
Elliott, BD; Johnson, R; Langer, O; Prihoda, T; Schenker, S | 1 |
Ammälä, C; Berggren, PO; Bertorello, AM; Bokvist, K; Chibalin, A; Deeney, JT; Eliasson, L; Flatt, PR; Gäbel, J; Gromada, J; Larsson, O; Lindström, P; Renström, E; Rhodes, CJ; Rorsman, P | 1 |
Gross, AS; Rieutord, A; Shenfield, GM; Stupans, I | 1 |
Selvaag, E | 1 |
Bernardi, G; Calabresi, P; Centonze, D; Pisani, A | 1 |
Abenhaim, L; Monette, J; van Staa, T | 1 |
Luo, M; O'Brien, RC | 1 |
Bernardi, G; Federici, M; Guatteo, E; Knöpfel, T; Mercuri, NB; Siniscalchi, A | 1 |
Bataille, D; Blache, P; Gros, L; Salazar, G; Virsolvy, A | 1 |
Brioni, JD; Gopalakrishnan, M; Molinari, EJ; Monteggia, LM; Roch, JM; Scott, VE; Shieh, CC; Sullivan, JP; Whiteaker, KL | 1 |
Galli Kienle, M; Magni, F; Marazzini, L; Monti, L; Pereira, S | 1 |
de Smet, PA; Fischer, HR | 1 |
Argüelles, CF; Granados-Soto, V; Ortiz, MI | 1 |
Andersson, C; Gislason, GH; Hansen, PR; Jørgensen, CH; Køber, L; Mérie, C; Norgaard, ML; Olesen, JB; Schmiegelow, M; Sørensen, R; Torp-Pedersen, C; Vaag, A; Weeke, P | 1 |
Abdelmoneim, AS; Brocks, DR; Hasenbank, SE; Light, PE; Seubert, JM; Simpson, SH | 1 |
Cui, G; McCarty, NA; Song, B; Turki, HW | 1 |
Jung, JS; Kim, CH; Kim, SJ; Kim, SS; Lim, SM; Park, SH; Sim, YB; Suh, HW | 1 |
Andersson, C; Fosbøl, EL; Gislason, G; Køber, L; Mogensen, UM; Scheller, NM; Schramm, TK; Torp-Pedersen, C; Vaag, A | 1 |
Azoulay, L; Douros, A; Filion, KB; Suissa, S; Yin, H; Yu, OHY | 1 |
Jannetto, PJ; Langman, LJ | 1 |
4 review(s) available for glipizide and tolbutamide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
["First" and "second" generation sulfonylureas: distinction or difference? (author's transl)].
Topics: Animals; Chlorpropamide; Dose-Response Relationship, Drug; Glipizide; Glyburide; Half-Life; Humans; Hypoglycemic Agents; Kinetics; Structure-Activity Relationship; Sulfonylurea Compounds; Tolbutamide | 1978 |
[Timing of administration of sulfonyl urea derivatives].
Topics: Biological Availability; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Administration Schedule; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Tolbutamide | 2000 |
Variations in tissue selectivity amongst insulin secretagogues: a systematic review.
Topics: Animals; ATP-Binding Cassette Transporters; Carbamates; Cardiovascular Diseases; Cricetinae; Cyclohexanes; Diabetes Mellitus, Type 2; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Ischemic Preconditioning, Myocardial; Isoindoles; Mice; Muscle, Smooth, Vascular; Myocytes, Cardiac; Nateglinide; Phenylalanine; Piperidines; Potassium Channels, Inwardly Rectifying; Rats; Receptors, Drug; Risk Factors; Sulfonylurea Compounds; Sulfonylurea Receptors; Tolbutamide | 2012 |
6 trial(s) available for glipizide and tolbutamide
Article | Year |
---|---|
Insulin in portal, hepatic and peripheral venous blood after glucose, tolbutamide and glipizide stimulation. Indication of insulin release from peripheral tissues.
Topics: Adult; Aged; Blood Glucose; Female; Glipizide; Glucose; Hepatic Veins; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Male; Middle Aged; Portal Vein; Sulfonylurea Compounds; Tolbutamide; Veins | 1979 |
Clinical evaluation of a new sulfonylurea in maturity onset diabetes - glipizide (K-4024).
Topics: Adult; Aged; Chlorpropamide; Clinical Trials as Topic; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Evaluation; Drug Therapy, Combination; Follow-Up Studies; Glipizide; Humans; Middle Aged; Phenformin; Sulfonylurea Compounds; Tolbutamide | 1976 |
Efficacy of gliclazide in comparison with other sulphonylureas in the treatment of NIDDM.
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diet, Diabetic; Gliclazide; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Tolbutamide | 1991 |
Glipizide versus tolbutamide, an open trial. Effects on insulin secretory patterns and glucose concentrations.
Topics: Aged; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus; Fasting; Female; Glipizide; Glucose Tolerance Test; Humans; Insulin; Male; Middle Aged; Placebos; Sulfonylurea Compounds; Tolbutamide | 1980 |
A study of the possible interaction of indoprofen with hypoglycemic sulfonylureas in diabetic patients.
Topics: Aged; Blood Glucose; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Drug Interactions; Female; Glipizide; Humans; Hypoglycemic Agents; Indoprofen; Male; Middle Aged; Osteoarthritis; Phenylpropionates; Sulfonylurea Compounds; Tolbutamide | 1981 |
Propranolol does not inhibit sulphonylurea-stimulated insulin secretion in patients with non-insulin dependent diabetes mellitus.
Topics: Aged; Blood Glucose; C-Peptide; Clinical Trials as Topic; Diabetes Mellitus; Double-Blind Method; Female; Glipizide; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Propranolol; Random Allocation; Sulfonylurea Compounds; Tolbutamide | 1982 |
59 other study(ies) available for glipizide and tolbutamide
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
High-performance liquid chromatographic determination of glipizide and some other sulfonylurea drugs in serum.
Topics: Chlorpropamide; Chromatography, High Pressure Liquid; Glipizide; Glyburide; Humans; Hydrogen-Ion Concentration; Sulfonylurea Compounds; Tolbutamide | 1979 |
Dynamics of sulfonylurea-induced insulin release from the isolated perfused rat pancreas.
Topics: Animals; Glipizide; Glyburide; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Male; Perfusion; Rats; Sulfonylurea Compounds; Tolbutamide | 1976 |
Biosynthesis of proinsulin and insulin in newborn rat pancreas. Interaction of glucose, cyclic AMP, somatostatin, and sulfonylureas on the (3H) leucine incorporation into immunoreactive insulin.
Topics: Animals; Animals, Newborn; Antigens; Cyclic AMP; Glipizide; Glucose; Humans; Insulin; Islets of Langerhans; Leucine; Proinsulin; Rats; Somatostatin; Sulfonylurea Compounds; Theophylline; Tolbutamide | 1976 |
Circular dichroism studies on the interaction of sulfonylureas with bovine and human serum albumin.
Topics: Binding Sites; Binding, Competitive; Carbutamide; Chlorpropamide; Circular Dichroism; Glipizide; Glyburide; Humans; In Vitro Techniques; Optical Rotatory Dispersion; Protein Binding; Serum Albumin; Serum Albumin, Bovine; Sulfonylurea Compounds; Tolbutamide | 1976 |
[Experimental study of glipizide. A comparison with other hypoglycemic sulfonamides (author's transl)].
Topics: Administration, Oral; Ammonia; Animals; Dogs; Dose-Response Relationship, Drug; Female; Glipizide; Glyburide; Injections, Intravenous; Insulin; Islets of Langerhans; Mice; Purine-Pyrimidine Metabolism, Inborn Errors; Rats; Seizures; Sulfonylurea Compounds; Time Factors; Tolbutamide | 1975 |
[Non-saturable cooperative binding of tolbutamide to rat endocrine pancreas. Criteria of specificity].
Topics: Animals; Diazoxide; Drug Interactions; Glipizide; Glucose; Glyburide; Islets of Langerhans; Kinetics; Rats; Tolbutamide | 1976 |
Specificity of photolabeling of beta-cell membrane proteins with an 125I-labeled glyburide analog.
Topics: Animals; Binding Sites; Cell Membrane; Chromatography, Gel; Cricetinae; Electrophoresis, Polyacrylamide Gel; Glipizide; Glyburide; Iodine Radioisotopes; Islets of Langerhans; Membrane Proteins; Photochemistry; Substrate Specificity; Tolbutamide; Tumor Cells, Cultured | 1992 |
Divergent cardiac effects of the first and second generation hypoglycemic sulfonylurea compounds.
Topics: Animals; Arrhythmias, Cardiac; Blood Glucose; Carbutamide; Dose-Response Relationship, Drug; Electrocardiography; Gliclazide; Glipizide; Glyburide; Hypoglycemic Agents; Male; Myocardial Infarction; Potassium; Rats; Rats, Inbred Strains; Reference Values; Structure-Activity Relationship; Tolbutamide | 1990 |
A screening test for detecting sulfonylureas in plasma.
Topics: Aged; Aged, 80 and over; Chlorpropamide; Chromatography, High Pressure Liquid; Female; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemia; Male; Middle Aged; Sulfonylurea Compounds; Tolbutamide | 1990 |
Effect of sulphonylurea therapy on insulin sensitivity in non insulin dependent diabetics.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Glipizide; Glyburide; Humans; Insulin Resistance; Middle Aged; Sulfonylurea Compounds; Time Factors; Tolbutamide | 1990 |
Modulation of glucose metabolism by sulfonylureas in primary cultures of adult rat hepatocytes.
Topics: Animals; Cells, Cultured; Fructosediphosphates; Glipizide; Glucose; Insulin; Lactates; Liver; Phosphofructokinase-1; Rats; Rats, Inbred Strains; Tolbutamide | 1990 |
Concentration-dependent effects of tolbutamide, meglitinide, glipizide, glibenclamide and diazoxide on ATP-regulated K+ currents in pancreatic B-cells.
Topics: Adenosine Triphosphate; Animals; Benzamides; Diazoxide; Glipizide; Glyburide; Hypoglycemic Agents; In Vitro Techniques; Ion Channels; Islets of Langerhans; Mice; Mice, Inbred Strains; Potassium; Sulfonylurea Compounds; Tolbutamide | 1988 |
Inhibition by sulphonylureas of vasorelaxation induced by K+ channel activators in vitro.
Topics: Animals; Antihypertensive Agents; Benzopyrans; Cromakalim; Drug Interactions; Glipizide; Glyburide; Guanidines; In Vitro Techniques; Male; Nifedipine; Norepinephrine; Pinacidil; Potassium Channels; Potassium Chloride; Pyrroles; Rabbits; Sulfonylurea Compounds; Tolbutamide; Vasodilator Agents | 1989 |
Effect of sulfonylureas on hepatic glycogen metabolism: activation of glycogen phosphorylase.
Topics: Animals; Cell Separation; Dose-Response Relationship, Drug; Enzyme Activation; Glipizide; Glucose; Glycogen; Liver; Phosphorylases; Rats; Sulfonylurea Compounds; Tolbutamide | 1989 |
Effect of glipizide on hepatic fructose 2,6-bisphosphate concentration and glucose metabolism.
Topics: Animals; Chlorpropamide; Cyclic AMP; Fructosediphosphates; Glipizide; Gluconeogenesis; Glucose; Hexosediphosphates; Hexosephosphates; In Vitro Techniques; Lactates; Liver; Male; Rats; Rats, Inbred Strains; Sulfonylurea Compounds; Tolbutamide | 1987 |
Sulphonamide modulation of sodium content in rat pancreatic islets.
Topics: Animals; Calcium; Diazoxide; Glipizide; Glucose; Islets of Langerhans; Male; Potassium; Rats; Rats, Inbred Strains; Sodium; Sulfonamides; Tolbutamide | 1988 |
Direct effects of sulfonylurea agents on glucose transport in the BC3H-1 myocyte.
Topics: Animals; Cell Line; Deoxy Sugars; Deoxyglucose; Glipizide; Glyburide; Hypoglycemic Agents; Insulin; Kinetics; Mice; Muscles; Tolbutamide | 1987 |
Characterization of the sulfonylurea receptor on beta cell membranes.
Topics: Animals; ATP-Binding Cassette Transporters; Cell Line; Cell Membrane; Cricetinae; Glipizide; Glyburide; Insulin; Islets of Langerhans; Kinetics; Potassium Channels; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Sulfonylurea Compounds; Sulfonylurea Receptors; Temperature; Tolazamide; Tolbutamide | 1988 |
Glibenclamide is exceptional among hypoglycaemic sulphonylureas in accumulating progressively in beta-cell-rich pancreatic islets.
Topics: Animals; Carbutamide; Chlorpropamide; Glipizide; Glyburide; Islets of Langerhans; Mice; Mice, Obese; Sulfonylurea Compounds; Tolbutamide | 1984 |
Sulfonylureas enhance in vivo the effectiveness of insulin in type 1 (insulin dependent) diabetes mellitus.
Topics: Adolescent; Adult; Chlorpropamide; Diabetes Mellitus, Type 1; Drug Interactions; Female; Glipizide; Humans; Insulin; Male; Sulfonylurea Compounds; Tolbutamide | 1984 |
Clinical pharmacology of glipizide.
Topics: Biological Availability; Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Glipizide; Glyburide; Half-Life; Humans; Kinetics; Structure-Activity Relationship; Sulfonylurea Compounds; Tolbutamide | 1983 |
Glipizide: experimental study and comparison with other sulfonylureas.
Topics: Animals; Blood Glucose; Dogs; Dose-Response Relationship, Drug; Glipizide; Glyburide; Hypoglycemia; Insulin; Islets of Langerhans; Mice; Rats; Sulfonylurea Compounds; Tolbutamide | 1980 |
Kinetics-effect relations of glipizide and other sulfonylureas.
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus; Dose-Response Relationship, Drug; Fasting; Feeding Behavior; Glipizide; Glyburide; Humans; Kidney; Sulfonylurea Compounds; Tolbutamide | 1980 |
Comparative single-dose kinetics and effects of four sulfonylureas in healthy volunteers.
Topics: Adult; Blood Glucose; Chlorpropamide; Fasting; Glipizide; Glyburide; Humans; Insulin; Kinetics; Male; Sulfonylurea Compounds; Time Factors; Tolbutamide | 1980 |
Homologous and hybrid calcium complexes of A23187 and hypoglycemic sulfonylureas: nuclear magnetic resonance and conformational analysis.
Topics: Anti-Bacterial Agents; Calcimycin; Calcium; Chemical Phenomena; Chemistry; Gliclazide; Glipizide; Magnetic Resonance Spectroscopy; Molecular Conformation; Sulfonylurea Compounds; Tolbutamide | 1982 |
Electron-capture gas chromatography of plasma sulphonylureas after extractive methylation.
Topics: Chromatography, Gas; Gas Chromatography-Mass Spectrometry; Glipizide; Humans; Sulfonylurea Compounds; Tolbutamide | 1980 |
Effects of gliclazide--a new antidiabetic agent--on blood platelet function in vitro and in vivo.
Topics: Adenosine Diphosphate; Animals; Collagen; Female; Gliclazide; Glipizide; Hemostasis; Humans; In Vitro Techniques; Lasers; Male; Microcirculation; Platelet Aggregation; Rabbits; Sulfonylurea Compounds; Tolbutamide | 1980 |
Photoaffinity labeling of the cerebral sulfonylurea receptor using a novel radioiodinated azidoglibenclamide analogue.
Topics: Affinity Labels; Animals; ATP-Binding Cassette Transporters; Binding, Competitive; Cell Fractionation; Cerebral Cortex; Electrophoresis, Polyacrylamide Gel; Glipizide; Glyburide; Iodine Radioisotopes; Kinetics; Microsomes; Molecular Weight; Photolysis; Potassium Channels; Potassium Channels, Inwardly Rectifying; Radioligand Assay; Receptors, Drug; Sulfonylurea Receptors; Swine; Tolbutamide; Tritium | 1994 |
Comparative placental transport of oral hypoglycemic agents in humans: a model of human placental drug transfer.
Topics: Administration, Oral; Analysis of Variance; Antipyrine; Biological Transport; Chlorpropamide; Chromatography, High Pressure Liquid; Female; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Maternal-Fetal Exchange; Models, Biological; Molecular Weight; Placenta; Pregnancy; Regression Analysis; Tolbutamide | 1994 |
PKC-dependent stimulation of exocytosis by sulfonylureas in pancreatic beta cells.
Topics: Animals; Calcium; Cells, Cultured; Cytoplasmic Granules; Electric Conductivity; Exocytosis; Glipizide; Glyburide; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Membrane Potentials; Mice; Patch-Clamp Techniques; Protein Kinase C; Sulfonylurea Compounds; Tolbutamide | 1996 |
Gliclazide hydroxylation by rat liver microsomes.
Topics: Animals; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Gliclazide; Glipizide; Glyburide; Hydroxylation; Hypoglycemic Agents; Kinetics; Male; Microsomes, Liver; Mixed Function Oxygenases; Rats; Rats, Sprague-Dawley; Tolbutamide | 1995 |
Photohemolytic potency of oral antidiabetic drugs in vitro: effects of antioxidants and a nitrogen atmosphere.
Topics: Antioxidants; Ascorbic Acid; Carbutamide; Chlorpropamide; Dose-Response Relationship, Drug; Gliclazide; Glipizide; Glyburide; Hemolysis; Humans; Hypoglycemic Agents; Nitrogen; Radiation-Sensitizing Agents; Reactive Oxygen Species; Sulfonamides; Sulfonylurea Compounds; Superoxide Dismutase; Tolazamide; Tolbutamide; Ultraviolet Rays; Vitamin E | 1996 |
Endogenous adenosine mediates the presynaptic inhibition induced by aglycemia at corticostriatal synapses.
Topics: Adenosine; Animals; Caffeine; Cerebral Cortex; Corpus Striatum; Evoked Potentials; Glipizide; Glucose; Glutamic Acid; Hypoglycemic Agents; In Vitro Techniques; Membrane Potentials; Neurons; Potassium Channel Blockers; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Synapses; Theophylline; Tolbutamide; Xanthines | 1997 |
Rates of hypoglycemia in users of sulfonylureas.
Topics: Adult; Aged; Chlorpropamide; Female; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Incidence; Male; Middle Aged; Poisson Distribution; Risk; Risk Factors; Sulfonylurea Compounds; Surveys and Questionnaires; Time Factors; Tolbutamide | 1997 |
The effects of gliclazide and other sulfonylureas on low-density lipoprotein oxidation in vitro.
Topics: Administration, Oral; Adult; Antioxidants; Ascorbic Acid; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Lipoproteins, LDL; Male; Middle Aged; Oxidation-Reduction; Sulfonylurea Compounds; Tolbutamide | 1997 |
Whole cell patch-clamp recordings of rat midbrain dopaminergic neurons isolate a sulphonylurea- and ATP-sensitive component of potassium currents activated by hypoxia.
Topics: Adenosine Triphosphate; Animals; Barium Compounds; Cell Hypoxia; Charybdotoxin; Chlorides; Dopamine; Glipizide; Glyburide; In Vitro Techniques; Membrane Potentials; Mesencephalon; Microelectrodes; Neurons; Patch-Clamp Techniques; Potassium Channels; Rats; Rats, Wistar; Reaction Time; Sulfonylurea Compounds; Tolbutamide | 1998 |
Characterization of low-affinity binding sites for glibenclamide on the Kir6.2 subunit of the beta-cell KATP channel.
Topics: Animals; ATP-Binding Cassette Transporters; Binding Sites; Blotting, Northern; Cell Line; Cell Membrane; COS Cells; Gliclazide; Glipizide; Glyburide; Islets of Langerhans; Kinetics; Organelles; Phentolamine; Potassium Channels; Potassium Channels, Inwardly Rectifying; Rats; Receptors, Drug; Recombinant Fusion Proteins; Sulfonylurea Compounds; Sulfonylurea Receptors; Tolbutamide; Transfection | 1999 |
Pharmacology of human sulphonylurea receptor SUR1 and inward rectifier K(+) channel Kir6.2 combination expressed in HEK-293 cells.
Topics: ATP-Binding Cassette Transporters; Binding, Competitive; Cations; Cell Line; Deoxyglucose; Diazoxide; Dose-Response Relationship, Drug; Electric Stimulation; Electrophysiology; Fluorescence; Gene Expression; Glipizide; Glyburide; Humans; Membrane Potentials; Oligomycins; Potassium Channels; Potassium Channels, Inwardly Rectifying; Radioligand Assay; Receptors, Drug; Recombinant Fusion Proteins; RNA, Messenger; Sulfonylurea Compounds; Sulfonylurea Receptors; Tolazamide; Tolbutamide; Tritium | 2000 |
Identification of sulfonylureas in serum by electrospray mass spectrometry.
Topics: Calibration; Chlorpropamide; Chromatography, Liquid; Glipizide; Glyburide; Humans; Mass Spectrometry; Models, Chemical; Sulfonylurea Compounds; Tolbutamide; Ultraviolet Rays | 2000 |
The peripheral antinociceptive effect of resveratrol is associated with activation of potassium channels.
Topics: 4-Aminopyridine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apamin; ATP-Binding Cassette Transporters; Charybdotoxin; Female; Glipizide; Glyburide; KATP Channels; Morphine; Narcotics; Peripheral Nervous System; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Calcium-Activated; Potassium Channels, Inwardly Rectifying; Rats; Rats, Wistar; Resveratrol; Stilbenes; Tetraethylammonium; Tolbutamide | 2002 |
Comparable long-term mortality risk associated with individual sulfonylureas in diabetes patients with heart failure.
Topics: Aged; Aged, 80 and over; Diabetes Mellitus; Female; Glipizide; Glyburide; Heart Failure; Humans; Hypoglycemic Agents; Male; Sulfonylurea Compounds; Tolbutamide | 2011 |
Differential contribution of TM6 and TM12 to the pore of CFTR identified by three sulfonylurea-based blockers.
Topics: Alanine; Amino Acid Sequence; Animals; Benzamides; Cystic Fibrosis Transmembrane Conductance Regulator; Glipizide; Glyburide; Ion Channel Gating; Kinetics; Mutagenesis; Oocytes; Patch-Clamp Techniques; Sulfonylurea Compounds; Tolbutamide; Xenopus | 2012 |
Effect of tolbutamide, glyburide and glipizide administered supraspinally on CA3 hippocampal neuronal cell death and hyperglycemia induced by kainic acid in mice.
Topics: Animals; Blood Glucose; CA3 Region, Hippocampal; Cell Death; Glipizide; Glyburide; Hyperglycemia; Hypoglycemic Agents; Infusions, Intraventricular; Kainic Acid; Male; Mice; Mice, Inbred ICR; Neurons; Sulfonylurea Compounds; Tolbutamide | 2014 |
Metformin in combination with various insulin secretagogues in type 2 diabetes and associated risk of cardiovascular morbidity and mortality--a retrospective nationwide study.
Topics: Aged; Carbamates; Cardiovascular Diseases; Denmark; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Morbidity; Myocardial Infarction; Piperidines; Registries; Retrospective Studies; Risk Factors; Stroke; Sulfonylurea Compounds; Tolbutamide | 2015 |
Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events.
Topics: Aged; Aged, 80 and over; Body Mass Index; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Gliclazide; Glipizide; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Incidence; Male; Middle Aged; Myocardial Infarction; Pancreas; Proportional Hazards Models; Risk Factors; Stroke; Sulfonylurea Compounds; Tolbutamide; United Kingdom | 2017 |
Analysis of Hypoglycemic Drugs by Liquid Chromatography-Tandem Mass Spectrometry.
Topics: Chlorpropamide; Chromatography, High Pressure Liquid; Chromatography, Liquid; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Nateglinide; Pioglitazone; Rosiglitazone; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Tolazamide; Tolbutamide | 2024 |